Haemophilia: open trials in Croatia

• NCT05145127

  Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

  Trial Treatment · Phase 3 · Pfizer

  KBC Zagreb, Grad Zagreb · University Hospital Centre Zagreb, Grad Zagreb

  Registry updated 2026-10-26

• NCT04023019

  Treatment of Hemophilia A Patients With FVIII Inhibitors

  Research · Phase 4 · Emory University

  University Hospital Centre Zagreb, Zagreb

  Registry updated 2026-09-23

• NCT03745924

  A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

  Research · Novo Nordisk A/S

  KBC Zagreb_Hematology, Zagreb

  Registry updated 2026-06-12

• NCT03695978

  Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

  Research · Octapharma

  University Hospital Centre Zagreb, Zagreb

  Registry updated 2026-06-02

• NCT05935358

  Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study

  Trial Treatment · Phase 4 · Octapharma

  University Hospital Centre Zagreb, Zagreb

  Registry updated 2026-05-12

• NCT04574076

  A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®

  Research · Novo Nordisk A/S

  KBC Zagreb, Rebro, Hemofilija centar, Zagreb

  Registry updated 2025-12-22

• 2022-502060-21-00

  Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)

  Trial Treatment · Phase 4 · Octapharma AG

  University Hospital Centre Zagreb, Grad Zagreb

  Registry updated 2025-09-25

All Haemophilia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error